All Articles

Management of metabolic dysfunction and cardiovascular risk in patients with MASLD

Research and clinical trial design in patients with metabolic dysfunction and alcohol-associated steatotic liver disease (MetALD): a narrative review

Extrahepatic manifestation of metabolic dysfunction-associated steatotic liver disease

Fatty liver disease in the pediatric population: history, definitions, and challenges in nomenclature (NAFLD/MAFLD/MASLD)

Dual etiology vs. MetALD: how MAFLD and MASLD address liver diseases coexistence

From NAFLD to MASLD: transforming steatotic liver disease diagnosis and management

NAFLD to MAFLD: collaboration, not confusion - rethinking the naming of fatty liver disease

A comprehensive review of patient-reported outcomes in metabolic dysfunction-associated steatotic liver disease

Metabolic dysfunction-associated steatotic liver disease: a key factor in hepatocellular carcinoma therapy response

From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction

Noninvasive testing in the diagnosis of metabolic dysfunction-associated steatohepatitis

Lower hepatic CBS and PEMT expression in advanced NAFLD: inferencing strategies to lower homocysteine with a mathematical model

Could controversies in the arena of fatty liver disease be a potential gate for the democratization of science?

Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review

MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?

Is liver fibrosis a risk factor for gynecological cancers?

Non-metabolic causes of steatotic liver disease

Concise review: Breastfeeding, lactation, and NAFLD. An updated view of cross-generational disease transmission and prevention